Literature DB >> 35391604

A novel frameshift mutation in Allan-Herndon-Dudley syndrome.

Zihao Liu1, Shuquan Zhao1, Jianyi Chen1, Longda Ma1, Qing Shi1, Yiwu Zhou2.   

Abstract

Allan-Herndon-Dudley syndrome (AHDS) is a very rare, X-linked psychomotor disability syndrome with delayed myelination, almost exclusively affecting boys. We present a case of a 4-year-old boy with AHDS who was found cyanotic, with intermittent vomiting and paroxysmal convulsions about 4 h after his parents went out, and was then taken to the hospital, where he eventually died the next day. The autopsy revealed foreign bodies in the tiny bronchi and alveoli of the deceased, congestion, and punctate hemorrhage in multiple organs, consistent with the diagnosis of asphyxia. Compared with a normally developing 4-year-old boy, the deceased showed cerebral atrophy and cerebral edema, and Luxol Fast Blue (LFB) stain indicated delayed cerebellar, hippocampal, and basal ganglia development and myelination. A novel frameshift mutation c.584delG in the SLC16A2 gene was detected. Family lineage investigation showed that the mutation was also detected in the deceased's 8-year-old brother and biological mother. The present work enriches the profile mutations in SLC16A2 related to AHDS and emphasizes the importance of autopsy and postmortem genetic analysis in such cases.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Allan-Herndon-Dudley syndrome; Forensic pathology; Monocarboxylate transporter 8; Myelination; SLC16A2 gene

Mesh:

Substances:

Year:  2022        PMID: 35391604     DOI: 10.1007/s00414-022-02823-z

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  22 in total

1.  Extended clinical phenotype, endocrine investigations and functional studies of a loss-of-function mutation A150V in the thyroid hormone specific transporter MCT8.

Authors:  Heike Biebermann; Petra Ambrugger; Patrick Tarnow; Arpad von Moers; Ulrich Schweizer; Annette Grueters
Journal:  Eur J Endocrinol       Date:  2005-09       Impact factor: 6.664

2.  Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene.

Authors:  Charles E Schwartz; Melanie M May; Nancy J Carpenter; R Curtis Rogers; Judith Martin; Martin G Bialer; Jewell Ward; Javier Sanabria; Silvana Marsa; James A Lewis; Roberto Echeverri; Herbert A Lubs; Kytja Voeller; Richard J Simensen; Roger E Stevenson
Journal:  Am J Hum Genet       Date:  2005-05-11       Impact factor: 11.025

Review 3.  The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome.

Authors:  Charles E Schwartz; Roger E Stevenson
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2007-06       Impact factor: 4.690

4.  Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation.

Authors:  Edith C H Friesema; Annette Grueters; Heike Biebermann; Heiko Krude; Arpad von Moers; Maarten Reeser; Timothy G Barrett; Edna E Mancilla; Johan Svensson; Monique H A Kester; George G J M Kuiper; Sahila Balkassmi; André G Uitterlinden; Josef Koehrle; Patrice Rodien; Andrew P Halestrap; Theo J Visser
Journal:  Lancet       Date:  2004 Oct 16-22       Impact factor: 79.321

5.  A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene.

Authors:  Alexandra M Dumitrescu; Xiao-Hui Liao; Thomas B Best; Knut Brockmann; Samuel Refetoff
Journal:  Am J Hum Genet       Date:  2003-12-05       Impact factor: 11.025

6.  Clinical phenotype and endocrinological investigations in a patient with a mutation in the MCT8 thyroid hormone transporter.

Authors:  Noriyuki Namba; Yuri Etani; Taichi Kitaoka; Yasuko Nakamoto; Mariko Nakacho; Kazuhiko Bessho; Yoko Miyoshi; Sotaro Mushiake; Ikuko Mohri; Hiroshi Arai; Masako Taniike; Keiichi Ozono
Journal:  Eur J Pediatr       Date:  2007-09-25       Impact factor: 3.183

7.  Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter.

Authors:  Edith C H Friesema; Sumita Ganguly; Amal Abdalla; Jocelyn E Manning Fox; Andrew P Halestrap; Theo J Visser
Journal:  J Biol Chem       Date:  2003-07-18       Impact factor: 5.157

8.  White matter abnormalities and dystonic motor disorder associated with mutations in the SLC16A2 gene.

Authors:  Artemis D Gika; Ata Siddiqui; Anthony J Hulse; Selvakumari Edward; Penny Fallon; Meriel E McEntagart; Wajanat Jan; Dragana Josifova; Tally Lerman-Sagie; James Drummond; Edward Thompson; Samuel Refetoff; Carsten G Bönnemann; Heinz Jungbluth
Journal:  Dev Med Child Neurol       Date:  2009-10-07       Impact factor: 5.449

9.  Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects.

Authors:  Catherine Vaurs-Barrière; Marlène Deville; Catherine Sarret; Geneviève Giraud; Vincent Des Portes; José-Maria Prats-Viñas; Giuseppe De Michele; Bernard Dan; Angela F Brady; Odile Boespflug-Tanguy; Renaud Touraine
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

10.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.